Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G, Gooren LJ, Rosing J.

J Clin Endocrinol Metab. 2003 Dec;88(12):5723-9.

PMID:
14671159
2.

Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.

Gooren LJ, Giltay EJ, Bunck MC.

J Clin Endocrinol Metab. 2008 Jan;93(1):19-25. Epub 2007 Nov 6. Review.

PMID:
17986639
3.
4.

Endocrine intervention for transsexuals.

Levy A, Crown A, Reid R.

Clin Endocrinol (Oxf). 2003 Oct;59(4):409-18. Review. No abstract available.

PMID:
14510900
5.

Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern.

Gooren LJ, Wierckx K, Giltay EJ.

Eur J Endocrinol. 2014 Jun;170(6):809-19. doi: 10.1530/EJE-14-0011. Epub 2014 Mar 10. Review.

6.

Effects of oral contraceptives on hemostasis and thrombosis.

Rosing J, Tans G.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S375-82. Review.

PMID:
10368524
7.

Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.

Moore E, Wisniewski A, Dobs A.

J Clin Endocrinol Metab. 2003 Aug;88(8):3467-73. Review.

PMID:
12915619
8.

Changes of hemostatic variables during oral contraceptive use.

Tans G, Bouma BN, B├╝ller HR, Rosing J.

Semin Vasc Med. 2003 Feb;3(1):61-8. Review.

PMID:
15199493
9.

[Hormonal treatment in transsexual patients. Metabolic consequences].

Corman V, Legros JJ.

Ann Endocrinol (Paris). 2007 Sep;68(4):258-64. Epub 2007 Aug 13. Review. French.

PMID:
17693385
10.

Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.

Mueller A, Gooren L.

Eur J Endocrinol. 2008 Sep;159(3):197-202. doi: 10.1530/EJE-08-0289. Epub 2008 Jun 20. Review.

11.

Cross-sex hormone therapy for gender dysphoria.

Fabris B, Bernardi S, Trombetta C.

J Endocrinol Invest. 2015 Mar;38(3):269-82. doi: 10.1007/s40618-014-0186-2. Epub 2014 Nov 18. Review.

PMID:
25403429
12.

Transsexuals and competitive sports.

Gooren LJ, Bunck MC.

Eur J Endocrinol. 2004 Oct;151(4):425-9. Review.

13.

(Patho)physiology of cross-sex hormone administration to transsexual people: the potential impact of male-female genetic differences.

Gooren LJ, Kreukels B, Lapauw B, Giltay EJ.

Andrologia. 2015 Feb;47(1):5-19. doi: 10.1111/and.12389. Epub 2014 Dec 11. Review.

PMID:
25495275
14.

Clinical review: Breast development in trans women receiving cross-sex hormones.

Wierckx K, Gooren L, T'Sjoen G.

J Sex Med. 2014 May;11(5):1240-7. doi: 10.1111/jsm.12487. Epub 2014 Mar 12. Review.

PMID:
24618412
15.

SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

Godano A, Maggi M, Jannini E, Meriggiola MC, Ghigo E, Todarello O, Lenzi A, Manieri C.

J Endocrinol Invest. 2009 Nov;32(10):857-64. No abstract available.

PMID:
20065624

Supplemental Content

Support Center